Combination of Remdesivir and Antibodies Didn’t Work Against COVID-19: Study The Epoch TimesHyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial The LancetCOVID-19: Highly concentrated antibody solution not effective treatment The Jerusalem PostNew trial tests the effectiveness of hyperimmune immunoglobulin for hospitalized COVID-19 patients News-Medical.NetHyperimmune intravenous immunoglobulin does not improve outcomes for adults hospitalized with COVID-19 National Institutes of HealthView Full Coverage on Google News